RET and medullary thyroid gland carcinoma: In particular, the so-called RET+3 SNP (rs2435357), affecting an intronic enhancer and thus reducing RET expression, presents a predisposing genetic factor for HSCR disease, while it is underrepresented in sporadic MTC[58,59].